The latest price target for Vaxart (NASDAQ:VXRT) was reported by Oppenheimer on August 15, 2024. The analyst firm set a price target for $4.00 expecting VXRT to rise to within 12 months (a possible 370.64% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Vaxart (NASDAQ:VXRT) was provided by Oppenheimer, and Vaxart initiated their outperform rating.

The last upgrade for Vaxart Inc happened on January 31, 2024 when B. Riley Securities raised their price target to $2. B. Riley Securities previously had a neutral for Vaxart Inc.

There is no last downgrade for Vaxart.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxart, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxart was filed on August 15, 2024 so you should expect the next rating to be made available sometime around August 15, 2025.

While ratings are subjective and will change, the latest Vaxart (VXRT) rating was a initiated with a price target of $0.00 to $4.00. The current price Vaxart (VXRT) is trading at is $0.85, which is within the analyst’s predicted range.